On September 24, 2025, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.
Following the success of its first edition in 2024, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier, Utrecht University, and SIRIC Montpellier Cancer, the program has been broadened to welcome new partners in 2025: the University of Barcelona, IHU Immun4cure, and FHU Evocan-2.
Organized within the framework of the Charm-EU alliance, this experimental module is open to Master’s students from all countries and disciplines, including medicine, biology, chemistry, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment, working in small, collaborative groups in a dynamic learning environment.
The inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24, 2025 in Montpellier (France). It will bring together clinicians, researchers, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet, exchange ideas, and innovate together. Following the conference, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies, supported by an international network of researchers committed to this topic.
This programme has been designed in collaboration with the SIRIC Montpellier Cancer, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa), the IHU Immune4cure and the FHU Evocan-2, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM), the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer
Practical Information:
Program Highlights:
Clinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.
Patient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies. Research Stakes Flash Presentations – Brief presentations on the latest research developments.
Round Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.
Online Event
This is a hybrid international event. A connection link will be sent to registered participants prior to the conference.
Languages
Simultaneous translation in French and English will be available.
Date & Venue
September 24, 2025, from 9:00 AM to 1:30 PM
Conference Room, Montpellier Cancer Research Institute (IRCM)
ICM Val d’Aurelle Campus, 208 Avenue des Apothicaires, Montpellier (France).
Register now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/
Contacts
Sonia Cantel: sonia.cantel@umontpellier.fr
Aurore Marquis: aurore.marquis@icm.unicancer.fr
Gilles Subra: gilles.subra@umontpellier.fr
Vanessa Vigano: vanessa.vigano@umontpellier.fr
